Abiopharma

🔍 Jassy Andrew R (Director)

Company: AMAZON COM INC (AMZN)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 50,000 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,255,766.00 | transaction_form_type: 4
• Sold 3,197 shares of Common Stock, par value $.01 per share at $257.6343 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,252,569.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 7,478 shares of Common Stock, par value $.01 per share at $258.6654 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,245,091.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 7,514 shares of Common Stock, par value $.01 per share at $259.6068 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,237,577.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,811 shares of Common Stock, par value $.01 per share at $260.3925 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,235,766.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Holds 0 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: In trust | shares_owned_after: 65,500.00
• Holds 0 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: Amazon.com 401(k) plan account | shares_owned_after: 9,927.40
• Sold 50,000 shares of Restricted Stock Unit Award (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2031-02-21 | Exercise: 2023-05-21 | equity_swap_involved: 0 | shares_owned_after: 900,000.00 | transaction_form_type: 4 | Footnotes: F6, F7

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2025.
• F2: Represents the weighted average sale price. The highest price at which shares were sold was $258.08 and the lowest price at which shares were sold was $257.09.
• F3: Represents the weighted average sale price. The highest price at which shares were sold was $259.14 and the lowest price at which shares were sold was $258.15.
• F4: Represents the weighted average sale price. The highest price at which shares were sold was $260.15 and the lowest price at which shares were sold was $259.18.
• F5: Represents the weighted average sale price. The highest price at which shares were sold was $260.90 and the lowest price at which shares were sold was $260.20.
• F6: Converts into Common Stock on a one-for-one basis.
• F7: This award vests based upon the following vesting schedule: 10,000 shares on each of May 21, 2023, August 21, 2023, November 21, 2023, and February 21, 2024; 20,000 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 25,000 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; and 50,000 shares on each of May 21, 2026, August 21, 2026, November 21, 2026, February 21, 2027, May 21, 2027, August 21, 2027, November 21, 2027, February 21, 2028, May 21, 2028, August 21, 2028, November 21, 2028, February 21, 2029, May 21, 2029, August 21, 2029, November 21, 2029, February 21, 2030, May 21, 2030, August 21, 2030, November 21, 2030, and February 21, 2031.
• REMARKS: The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.